Leash Biosciences Secures $9.3M Seed Funding to Revolutionize Drug Discovery with AI

Leash Biosciences aims to revolutionize medicinal chemistry with AI.

Source: Leash Biosciences

Company Name: Leash Biosciences
Location: Salt Lake City, UT
Sector: Biotechnology
Funding Details: Raised $9.3M in Seed funding from Springtide Ventures, MetaPlanet, Top Harvest Capital, Mitsui Global Investment, MFV Partners, and Recursion co-founders.
Purpose of Investment: To develop a foundational machine learning model of medicinal chemistry for predicting small molecule drug candidates.
Leadership: Led by CEO Ian Quigley.

Product: A platform that leverages machine learning to design novel small molecule therapeutics by analyzing chemical and biological datasets.

About Company: Leash Biosciences aims to revolutionize medicinal chemistry with AI. Having generated over 17 billion protein-chemical interaction measurements, the company plans to screen 500+ protein targets against millions of proprietary chemicals by 2025.

AI Funding News Week Ending 01.10

SoSoValue Raises $15M in Series A Funding to Advance AI-Driven Investment Research Platform

SoSoValue is redefining investment research by leveraging AI to help retail investors navigate complex financial data.

Oxford Cancer Analytics Raises $11M in Series A Funding to Advance Early Cancer Detection

OXcan’s innovative approach combines cutting-edge AI to detect deadly cancers early when treatment is most effective.

Read next